EZRA
Reliance Global Group, Inc.
$3.56
-5.20%
$2.0M
No data for this timeframe.
Vol
Market Cap$2.0M
Cap SizeNano Cap
Inst. Holders3 funds
Inst. Value$41.8K
Inst. Activity2 buys / 0 sells
Insider Activity1B / 5S
Insider Net $-$54.5K
Reddit Sentiment56° Neutral
SEC Reports5
Press Releases3
Recent Activity
Jun 3, 2026
SEC
Reliance Global Group (EZRA) announced it has regained compliance with Nasdaq's $1.00 minimum bid price requirement afte
8-K — Impact 4/10
Jun 3, 2026
other
Reliance Global Group Regains Compliance with Nasdaq Continued Listing Requirements
<p align="justify">LAKEWOOD, NJ, June 03, 2026 (GLOBE NEWSWIRE) -- <b>Reliance Global Group, Inc.
May 6, 2026
SEC
Reliance Global Group announces a conference call to discuss Q1 2026 results and provide a business update. No financial
PRESS-RELEASE — Impact 2/10
May 4, 2026
SEC
Reliance Global Group (EZRA) formed LifeSci Global Group (51% owned) to invest $2M in Innervate Radiopharmaceuticals, a
8-K — Impact 5/10
Mar 26, 2026
Insider
Beyman Ezra bought 300,000 shares
Chairman and CEO @ $0.1699 ($51.0K)
Mar 24, 2026
Insider
Markovits Joel sold 127,562 shares
Chief Financial Officer @ $0.2055 ($26.2K)
Nov 26, 2025
Insider
Markovits Joel sold 25,000 shares
Chief Financial Officer @ $0.6600 ($16.5K)
Inst.
VANGUARD GROUP INC — NEW
81,566 shares ($41.7K)
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
8-K
4/10
Reliance Global Group (EZRA) announced it has regained compliance with Nasdaq's $1.00 minimum bid price requirement afte
Jun 3, 2026
BEARISH
Press
5/10
Reliance Global Group announced a 1-for-40 reverse stock split to regain Nasdaq minimum bid price compliance. The split
May 14, 2026
NEUTRAL
PRESS-RELEASE
2/10
Reliance Global Group announces a conference call to discuss Q1 2026 results and provide a business update. No financial
May 6, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $41.7K | NEW |
| WELLS FARGO & COMPANY/MN | $124.00 | EXIT |
| BANK OF AMERICA CORP | $35.00 | DOUBLED |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 26, 2026 | Beyman Ezra | BUY | $51.0K |
| Mar 24, 2026 | Markovits Joel | SELL | $26.2K |
| Nov 26, 2025 | Markovits Joel | SELL | $16.5K |
| Sep 15, 2025 | Markovits Joel | F | $82.1K |
| Sep 15, 2025 | Beyman Ezra | F | $253.5K |
Reddit Sentiment
56°
Neutral
Bearish
Neutral
Bullish
3 institutional holders with $41.8K total value (81,877 shares) as of 2025-Q4. Top holders: VANGUARD, WELLS, BANK. Net buying activity: 2 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 81,566 | $41.7K | 99.6% | NEW |
| 2 | WELLS FARGO & COMPANY/MN | 242 | $124.00 | 0.3% | EXIT -100.0% |
| 3 | BANK OF AMERICA CORP /DE/ | 69 | $35.00 | 0.1% | DOUBLED +176.0% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | NEW | — | 81,566 | — | $41.7K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 25 | 69 | +176.0% | $35.00 | 2025-Q4 |
| UBS Group AG | TRIM | 17,131 | 7,760 | -54.7% | $7.1K | 2025-Q3 |
| UBS Group AG | ADD | 11,200 | 17,131 | +53.0% | $32.0K | 2025-Q2 |
| MORGAN STANLEY | DOUBLED | 1 | 230 | +22900.0% | $430.00 | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | ADD | 15 | 27 | +80.0% | $51.00 | 2025-Q2 |
| UBS Group AG | TRIM | 43,350 | 11,200 | -74.2% | $13.3K | 2025-Q1 |
| UBS Group AG | DOUBLED | 12,117 | 43,350 | +257.8% | $111.8K | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | EXIT | 10,437 | 0 | -100.0% | $0.00 | 2024-Q4 |
3 unique insiders with 6 transactions. Net insider value: -$54.5K ($51.0K bought, $105.5K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Beyman Ezra | Chairman and CEO | BUY | 300,000 | $0.1699 | $51.0K |
| Mar 24, 2026 | Markovits Joel | Chief Financial Officer | SELL | 127,562 | $0.2055 | $26.2K |
| Nov 26, 2025 | Markovits Joel | Chief Financial Officer | SELL | 25,000 | $0.6600 | $16.5K |
| Sep 15, 2025 | Markovits Joel | Chief Financial Officer | F | 93,808 | $0.8747 | $82.1K |
| Sep 15, 2025 | Beyman Ezra | Chairman and CEO | F | 289,780 | $0.8747 | $253.5K |
| Sep 15, 2025 | Beyman Yaakov | EXEC VP, INSURANCE DIVISION | F | 75,140 | $0.8747 | $65.7K |
| Sep 15, 2025 | Markovits Joel | Chief Financial Officer | SELL | 44,082 | $0.8166 | $36.0K |
| Sep 4, 2025 | Markovits Joel | Chief Financial Officer | SELL | 30,255 | $0.8795 | $26.6K |
| Sep 3, 2025 | Markovits Joel | Chief Financial Officer | SELL | 155 | $0.8800 | $136.40 |
| Sep 3, 2025 | Beyman Ezra | Chairman and CEO | F | 9,043 | $0.8838 | $8.0K |
| Sep 3, 2025 | Beyman Yaakov | EXEC VP, INSURANCE DIVISION | F | 2,181 | $0.8838 | $1.9K |
| Sep 3, 2025 | Markovits Joel | Chief Financial Officer | F | 6,717 | $0.8838 | $5.9K |
5 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 2 mixed, 2 neutral. Avg impact: 4.6/10.
NEUTRAL
8-K
4/10
Reliance Global Group (EZRA) announced it has regained compliance with Nasdaq's $1.00 minimum bid pr
Jun 3, 2026
NEUTRAL
PRESS-RELEASE
2/10
Reliance Global Group announces a conference call to discuss Q1 2026 results and provide a business
May 6, 2026
MIXED
8-K
5/10
Reliance Global Group (EZRA) formed LifeSci Global Group (51% owned) to invest $2M in Innervate Radi
May 4, 2026
MIXED
CLUSTER
5/10
Reliance Global Group CEO Beyman Ezra purchased $50,970 worth of shares in an open-market transactio
Mar 26, 2026
BULLISH
8-K
7/10
Reliance Global Group (EZRA) acquired an initial 8% stake in Israeli post-quantum cybersecurity firm
Feb 25, 2026
BEARISH
5/10
Reliance Global Group announced a 1-for-40 reverse stock split to regain Nasdaq minimum bid price co
May 14, 2026
NEUTRAL
4/10
Reliance Global Group (EZRA) funded a milestone in its strategic investment in Enquantum Ltd., a pos
Mar 19, 2026
MIXED
5/10
Reliance Global Group (EZRA) reported 2025 financial results showing a reduced net loss of $7.0M (fr
Mar 10, 2026
Historical analyst distribution: 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2023-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Feb 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jan 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Dec 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Nov 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
56°
Neutral
Bearish
Neutral
Bullish
4 mentions
2 bullish
1 bearish
4 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Mar 25, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 25, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Feb 26, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Feb 23, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
Jun 3, 2026
other
Reliance Global Group Regains Compliance with Nasdaq Continued Listing Requirements
<p align="justify">LAKEWOOD, NJ, June 03, 2026 (GLOBE NEWSWIRE) -- <b>Reliance Global Group, Inc. (Nasdaq: EZRA)</b> (“we,” “us,” “our,” the “Compan
Jun 1, 2026
other
Reliance Global Group Positions ENQUANTUM to Help Secure the Post-Quantum Economy Before “Q-Day”
Company Targets Multi-Billion-Dollar Cybersecurity Upgrade Cycle as Governments, Financial Institutions, AI Infrastructure Operators and Critical Netw
May 18, 2026
other
Reliance Global Group Provides Update on Enquantum Private 5G Deployment and Smart Infrastructure Initiatives
Israel Innovation Authority Approves Project Following Successful Real-World Construction Pilot Under EZRA International Group’s Scale51 Initiative <p
May 15, 2026
short_volume
Short Volume: EZRA — 63.5% short (1.1M / 1.8M)
Short: 1,128,607 | Exempt: 475,489 | TRF Vol: 1,776,988 | Short Ratio: 63.5% | Off-exchange volume (dark pool + OTC)
May 14, 2026
restatement
Reliance Global Group Announces Reverse Stock Split
<p align="justify">LAKEWOOD, NJ, May 14, 2026 (GLOBE NEWSWIRE) -- <b>Reliance Global Group, Inc. (Nasdaq: EZRA)</b> (“Reliance”, “we” or the “Compan
May 14, 2026
short_volume
Short Volume: EZRA — 61.0% short (1.7M / 2.7M)
Short: 1,653,008 | Exempt: 318,850 | TRF Vol: 2,707,687 | Short Ratio: 61.0% | Off-exchange volume (dark pool + OTC)
May 13, 2026
short_volume
Short Volume: EZRA — 60.5% short (0.5M / 0.8M)
Short: 455,813 | Exempt: 7,200 | TRF Vol: 753,669 | Short Ratio: 60.5% | Off-exchange volume (dark pool + OTC)
May 11, 2026
short_volume
Short Volume: EZRA — 55.4% short (0.5M / 0.8M)
Short: 451,736 | Exempt: 20,004 | TRF Vol: 816,091 | Short Ratio: 55.4% | Off-exchange volume (dark pool + OTC)
May 8, 2026
short_volume
Short Volume: EZRA — 60.5% short (0.8M / 1.4M)
Short: 825,238 | Exempt: 5,415 | TRF Vol: 1,363,588 | Short Ratio: 60.5% | Off-exchange volume (dark pool + OTC)
May 7, 2026
earnings
Reliance Global Group Reports First Quarter 2026 Results and Advances Scale51 Strategy Through Targeted Technology and Life Sciences Investments
<p align="center"><em>Company Expands Ownership-Driven Investment Model While Maintaining Insurance and InsurTech Operating Foundation</em></p>
May 6, 2026
earnings
Reliance Global Group Schedules First Quarter 2026 Financial Results and Business Update Conference Call
<p>Lakewood, NJ, May 06, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=MOJTJ1Q-s48GxgohQMp9-pVDekrJ8PyaUdBTzk21i7RcGr
May 6, 2026
short_volume
Short Volume: EZRA — 58.4% short (0.8M / 1.4M)
Short: 802,962 | Exempt: 500 | TRF Vol: 1,375,797 | Short Ratio: 58.4% | Off-exchange volume (dark pool + OTC)
May 5, 2026
other
Reliance Global Group Launches LifeSci Global, Its Dedicated Life Sciences Platform, Partnering with Proven Operators Scott Korman and David Turner to Build and Lead the Platform with Innervate Radiopharmaceuticals as the First Platform Investment
<p align="center"><em>LifeSci Global Launches as Reliance’s Life Sciences Platform, Partnering with Scott Korman and David Turner as Its Founding Oper
May 4, 2026
other
Reliance Global Group Completes Transformative Investment in Late-Stage Radiopharmaceutical Innovator Innervate Through EZRA’s Biotech Division
<p align="center"><em>Transaction Expands EZRA International Group’s Biotech Division, LifeSci Global, Into Late-Stage Radiopharmaceutical Imaging</em
May 4, 2026
short_volume
Short Volume: EZRA — 57.2% short (1.4M / 2.4M)
Short: 1,356,884 | Exempt: 14,551 | TRF Vol: 2,370,238 | Short Ratio: 57.2% | Off-exchange volume (dark pool + OTC)